Vascular dementia

Journal of the Neurological Sciences

Volumn 322, Issue 1-2, 2012, Pages 2-10

  Korczyn, Amos D ^a   Vakhapova, Veronika ^b   Grinberg, Lea T ^c,d  

^a TEL AVIV UNIVERSITY   (Israel)

^b Maccabi Health Foundation   (Israel)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Biomarkers; Cognitive impairment; Dementia; Diagnosis; Neuropathology; Stroke; Vascular

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; APOLIPOPROTEIN E; BIOLOGICAL MARKER; CEREBROLYSIN; CHOLESTEROL; CHOLINESTERASE INHIBITOR; CITICOLINE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; MEMANTINE; NITRENDIPINE; SATURATED FATTY ACID;

ACUPUNCTURE; AGING; ALZHEIMER DISEASE; ARTERIOSCLEROSIS; ARTICLE; BRAIN INFARCTION SIZE; CADASIL; CEREBROVASCULAR ACCIDENT; CLINICAL FEATURE; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DIFFERENTIAL DIAGNOSIS; EDUCATIONAL STATUS; FABRY DISEASE; GENETIC ASSOCIATION; GENETIC DISORDER; GINKGO BILOBA; HEAD INJURY; HISTOPATHOLOGY; HUMAN; HYPERCHOLESTEROLEMIA; HYPERHOMOCYSTEINEMIA; HYPERTENSION; LIPID DIET; MELAS SYNDROME; METABOLIC SYNDROME X; MILD COGNITIVE IMPAIRMENT; MULTIINFARCT DEMENTIA; OBESITY; PHENOTYPE; PRIMARY PREVENTION; PRIORITY JOURNAL; RENDU OSLER WEBER DISEASE; RISK ASSESSMENT; SECONDARY PREVENTION; SEX DIFFERENCE; SICKLE CELL ANEMIA; SMOKING; VASCULAR AMYLOIDOSIS;

ANIMALS; COGNITION DISORDERS; DEMENTIA, VASCULAR; HUMANS; RISK FACTORS;

EID: 84867577361     PISSN: 0022510X     EISSN: 18785883     Source Type: Journal    
DOI: 10.1016/j.jns.2012.03.027     Document Type: Article

References (126)

1. R.M. Sousa, C.P. Ferri, D. Acosta, E. Albanese, M. Guerra, and Y. Huang Contribution of chronic diseases to disability in elderly people in countries with low and middle incomes: a 10/66 Dementia Research Group population-based survey Lancet 374 2009 1821 1830
2. R.N. Kalaria, G.E. Maestre, R. Arizaga, R.P. Friedland, D. Galasko, and K. Hall Alzheimer's disease and vascular dementia in developing countries: prevalence, management, and risk factors Lancet Neurol 7 2008 812 826
3. J.J. Llibre Rodriguez, C.P. Ferri, D. Acosta, M. Guerra, Y. Huang, and K.S. Jacob Prevalence of dementia in Latin America, India, and China: a population-based cross-sectional survey Lancet 372 2008 464 474
4. A. Wimo, B. Winblad, and L. Jonsson The worldwide societal costs of dementia: estimates for 2009 Alzheimers Dement 6 2010 98 103
5. H. Brodaty, and M. Donkin Family caregivers of people with dementia Dialogues Clin Neurosci 11 2009 217 228
6. L.T. Grinberg, and H. Heinsen Toward a pathological definition of vascular dementia J Neurol Sci 299 2010 136 138
7. A.D. Korczyn, and V. Vakhapova The prevention of the dementia epidemic J Neurol Sci 257 2007 2 4
8. A.D. Korczyn Mixed dementia - the most common cause of dementia Ann N Y Acad Sci 977 2002 129 134
9. A.D. Korczyn The complex nosological concept of vascular dementia J Neurol Sci 203-204 2002 3 6
10. K.M. Langa, N.L. Foster, and E.B. Larson Mixed dementia: emerging concepts and therapeutic implications JAMA 292 2004 2901 2908
11. G.C. Roman, P. Sachdev, D.R. Royall, R.A. Bullock, J.M. Orgogozo, and S. Lopez-Pousa Vascular cognitive disorder: a new diagnostic category updating vascular cognitive impairment and vascular dementia J Neurol Sci 226 2004 81 87
12. B.E. Tomlinson, G. Blessed, and M. Roth Observations on the brains of non-demented old people J Neurol Sci 7 1968 331 356
13. V.C. Hachinski, N.A. Lassen, and J. Marshall Multi-infarct dementia. A cause of mental deterioration in the elderly Lancet 2 1974 207 210
14. V. Hachinski Vascular dementia: a radical redefinition Dementia 5 1994 130 132
15. H.C. Chui, W. Mack, J.E. Jackson, D. Mungas, B.R. Reed, and J. Tinklenberg Clinical criteria for the diagnosis of vascular dementia - a multicenter study of comparability and interrater reliability Arch Neurol 57 2000 191 196
16. D.S. Knopman, J.E. Parisi, B.F. Boeve, R.H. Cha, H. Apaydin, and A. Salviati Vascular dementia in a population-based autopsy study Arch Neurol 60 2003 569 575
17. G. Gold, P. Giannakopoulos, C. Montes-Paixao Junior, F.R. Herrmann, R. Mulligan, and J.P. Michel Sensitivity and specificity of newly proposed clinical criteria for possible vascular dementia Neurology 49 1997 690 694
18. J. Zaccai, P. Ince, and C. Brayne Population-based neuropathological studies of dementia: design, methods and areas of investigation - a systematic review BMC Neurol 6 2006 2
19. D. Leys, H. Henon, M.A. Mackowiak-Cordoliani, and F. Pasquier Poststroke dementia Lancet Neurol 4 2005 752 759
20. D. Leys, F. Pasquier, and L. Parnetti Epidemiology of vascular dementia Haemostasis 28 1998 134 150
21. L.E. Middleton, L.T. Grinberg, B. Miller, C. Kawas, and K. Yaffe Neuropathologic features associated with Alzheimer disease diagnosis: age matters Neurology 77 2011 1737 1744
22. M. Ikeda, K. Hokoishi, N. Maki, A. Nebu, N. Tachibana, and K. Komori Increased prevalence of vascular dementia in Japan: a community-based epidemiological study Neurology 57 2001 839 844
23. M. Yamada, Y. Mimori, F. Kasagi, T. Miyachi, T. Ohshita, and S. Sudoh Incidence of dementia, Alzheimer disease, and vascular dementia in a Japanese population: Radiation Effects Research Foundation adult health study Neuroepidemiology 30 2008 152 160
24. P.B. Gorelick, A. Scuteri, S.E. Black, C. Decarli, S.M. Greenberg, and C. Iadecola Vascular contributions to cognitive impairment and dementia: a statement for healthcare professionals from the American Heart Association/American Stroke Association Stroke 42 2011 2672 2713
25. M.S. Beeri, R. Ravona-Springer, J.M. Silverman, and V. Haroutunian The effects of cardiovascular risk factors on cognitive compromise Dialogues Clin Neurosci 11 2009 201 212
26. M.M. Mielke, P.B. Rosenberg, J. Tschanz, L. Cook, C. Corcoran, and K.M. Hayden Vascular factors predict rate of progression in Alzheimer disease Neurology 69 2007 1850 1858
27. D. Strozyk, D.W. Dickson, R.B. Lipton, M. Katz, C.A. Derby, and S. Lee Contribution of vascular pathology to the clinical expression of dementia Neurobiol Aging 31 2010 1710 1720
28. J.A. Schneider, Z. Arvanitakis, W. Bang, and D.A. Bennett Mixed brain pathologies account for most dementia cases in community-dwelling older persons Neurology 69 2007 2197 2204
29. K.M. Hayden, P.P. Zandi, C.G. Lyketsos, A.S. Khachaturian, L.A. Bastian, and G. Charoonruk Vascular risk factors for incident Alzheimer disease and vascular dementia: the Cache County study Alzheimer Dis Assoc Disord 20 2006 93 100
30. C. Raffaitin, H. Gin, J.P. Empana, C. Helmer, C. Berr, and C. Tzourio Metabolic syndrome and risk for incident Alzheimer's disease or vascular dementia: the Three-City Study Diabetes Care 32 2009 169 174
31. V. Solfrizzi, E. Scafato, C. Capurso, A. D'Introno, A.M. Colacicco, and V. Frisardi Metabolic syndrome and the risk of vascular dementia: the Italian Longitudinal Study on Ageing J Neurol Neurosurg Psychiatry 81 2010 433 440
32. G.W. Albers, L.B. Goldstein, D.C. Hess, L.R. Wechsler, K.L. Furie, and P.B. Gorelick Stroke Treatment Academic Industry Roundtable (STAIR) recommendations for maximizing the use of intravenous thrombolytics and expanding treatment options with intra-arterial and neuroprotective therapies Stroke 42 2011 2645 2650
33. W. Xu, C. Qiu, M. Gatz, N.L. Pedersen, B. Johansson, and L. Fratiglioni Mid- and late-life diabetes in relation to the risk of dementia: a population-based twin study Diabetes 58 2009 71 77
34. D.J. Werring, D.W. Frazer, L.J. Coward, N.A. Losseff, H. Watt, and L. Cipolotti Cognitive dysfunction in patients with cerebral microbleeds on T2*-weighted gradient-echo MRI Brain 127 2004 2265 2275
35. J. De Reuck, F. Auger, C. Cordonnier, V. Deramecourt, N. Durieux, and F. Pasquier Comparison of 7.0-T T*-magnetic resonance imaging of cerebral bleeds in post-mortem brain sections of Alzheimer patients with their neuropathological correlates Cerebrovasc Dis 31 2011 511 517
36. L.K. Kent, and P.A. Shapiro Depression and related psychological factors in heart disease Harv Rev Psychiatry 17 2009 377 388
37. S. Kumar, M.H. Selim, and L.R. Caplan Medical complications after stroke Lancet Neurol 9 2010 105 118
38. T. Pohjasvaara, T. Erkinjuntti, R. Ylikoski, M. Hietanen, R. Vataja, and M. Kaste Clinical determinants of poststroke dementia Stroke 29 1998 75 81
39. A.D. Korczyn, and I. Halperin Depression and dementia J Neurol Sci 283 2009 139 142
40. G.G. Leblanc, J.F. Meschia, D.T. Stuss, and V. Hachinski Genetics of vascular cognitive impairment: the opportunity and the challenges Stroke 37 2006 248 255
41. M. Kivipelto, E.L. Helkala, M.P. Laakso, T. Hanninen, M. Hallikainen, and K. Alhainen Apolipoprotein E epsilon4 allele, elevated midlife total cholesterol level, and high midlife systolic blood pressure are independent risk factors for late-life Alzheimer disease Ann Intern Med 137 2002 149 155
42. S. Abboud, L.E. Viiri, D. Lutjohann, S. Goebeler, T. Luoto, and S. Friedrichs Associations of apolipoprotein E gene with ischemic stroke and intracranial atherosclerosis Eur J Hum Genet 16 2008 955 960
43. E. Rowan, C.M. Morris, S. Stephens, C. Ballard, H. Dickinson, and H. Rao Impact of hypertension and apolipoprotein E4 on poststroke cognition in subjects > 75 years of age Stroke 36 2005 1864 1868
44. T.A. Treves, N.M. Bornstein, J. Chapman, S. Klimovitzki, R. Verchovsky, and A. Asherov APOE-epsilon 4 in patients with Alzheimer disease and vascular dementia Alzheimer Dis Assoc Disord 10 1996 189 191
45. J. Chapman, N. Wang, T.A. Treves, A.D. Korczyn, and N.M. Bornstein ACE, MTHFR, factor V Leiden, and APOE polymorphisms in patients with vascular and Alzheimer's dementia Stroke 29 1998 1401 1404
46. H. Koga, Y. Takashima, R. Murakawa, A. Uchino, T. Yuzuriha, and H. Yao Cognitive consequences of multiple lacunes and leukoaraiosis as vascular cognitive impairment in community-dwelling elderly individuals J Stroke Cerebrovasc Dis 18 2009 32 37
47. A. Handley, P. Medcalf, K. Hellier, and D. Dutta Movement disorders after stroke Age Ageing 38 2009 260 266
48. V. Hachinski, C. Iadecola, R.C. Petersen, M.M. Breteler, D.L. Nyenhuis, and S.E. Black National Institute of Neurological Disorders and Stroke-Canadian Stroke Network vascular cognitive impairment harmonization standards Stroke 37 2006 2220 2241
49. R.C. Petersen, G.E. Smith, S.C. Waring, R.J. Ivnik, E. Kokmen, and E.G. Tangelos Aging, memory, and mild cognitive impairment Int Psychogeriatr 9 Suppl. 1 1997 65 69
50. C. Wentzel, K. Rockwood, C. MacKnight, V. Hachinski, D.B. Hogan, and H. Feldman Progression of impairment in patients with vascular cognitive impairment without dementia Neurology 57 2001 714 716
51. D.S. Knopman, W.A. Rocca, R.H. Cha, S.D. Edland, and E. Kokmen Incidence of vascular dementia in Rochester, Minn, 1985-1989 Arch Neurol 59 2002 1605 1610
52. H.C. Chui, J.I. Victoroff, D. Margolin, W. Jagust, R. Shankle, and R. Katzman Criteria for the diagnosis of ischemic vascular dementia proposed by the State of California Alzheimer's Disease Diagnostic and Treatment Centers Neurology 42 1992 473 480
53. G.C. Roman, T.K. Tatemichi, T. Erkinjuntti, J.L. Cummings, J.C. Masdeu, and J.H. Garcia Vascular dementia - diagnostic criteria for research studies - report of the NINDS-AIREN international workshop Neurology 43 1993 250 260
54. World Health Organization The ICD-10 Classification of Mental and Behavioural Disorders: Clinical Descriptions and Diagnostic Guidelines. Geneva, Switzerland 1993 36 40
55. American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders Fourth Edition 1994 143 147 (DSM-IV). Washington, DC.
56. V. Hachinski, and T.Y. Lee Commentary on "Alzheimer's disease drug development and the problem of the blood-brain barrier." The blood-brain barrier: a physical and conceptual challenge Alzheimers Dement 5 2009 435 436
57. J.T. Moroney, E. Bagiella, D.W. Desmond, V.C. Hachinski, P.K. Molsa, and L. Gustafson Meta-analysis of the Hachinski ischemic score in pathologically verified dementias Neurology 49 1997 1096 1105
58. K.D. Garrett, R.H. Paul, D.J. Libon, and R.A. Cohen Defining the diagnosis of vascular dementia Appl Neuropsychol 11 2004 204 209
59. S.T. Pendlebury, and P.M. Rothwell Prevalence, incidence, and factors associated with pre-stroke and post-stroke dementia: a systematic review and meta-analysis Lancet Neurol 8 2009 1006 1018
60. M. Hoffmann, F. Schmitt, and E. Bromley Vascular cognitive syndromes: relation to stroke etiology and topography Acta Neurol Scand 120 2009 161 169
61. A. Bruandet, F. Richard, S. Bombois, C.A. Maurage, V. Deramecourt, and F. Lebert Alzheimer disease with cerebrovascular disease and vascular dementia: clinical features and course compared with Alzheimer disease J Neurol Neurosurg Psychiatry 80 2009 133 139
62. J.M. Orgogozo, A.S. Rigaud, A. Stoffler, H.J. Mobius, and F. Forette Efficacy and safety of memantine in patients with mild to moderate vascular dementia: a randomized, placebo-controlled trial (MMM 300) Stroke 33 2002 1834 1839
63. J.S. Meyer, M.H. Chowdhury, G. Xu, Y.S. Li, and M. Quach Donepezil treatment of vascular dementia Ann N Y Acad Sci 977 2002 482 486
64. A.P. Auchus, H.R. Brashear, S. Salloway, A.D. Korczyn, P.P. De Deyn, and C. Gassmann-Mayer Galantamine treatment of vascular dementia: a randomized trial Neurology 69 2007 448 458
65. J. Aharon-Peretz, E. Daskovski, T. Mashiach, and R. Tomer Natural history of dementia associated with lacunar infarctions J Neurol Sci 203 2002 53 55
66. G.M. Savva, and B.C. Stephan Epidemiological studies of the effect of stroke on incident dementia: a systematic review Stroke 41 2010 e41 e46
67. G.C. Newman, H. Bang, S.I. Hussain, and J.F. Toole Association of diabetes, homocysteine, and HDL with cognition and disability after stroke Neurology 69 2007 2054 2062
68. R. van der Linde, B.C. Stephan, F.E. Matthews, C. Brayne, and G.M. Savva Behavioural and psychological symptoms in the older population without dementia - relationship with socio-demographics, health and cognition BMC Geriatr 10 2010 87
69. V.K. Srikanth, S.J. Quinn, G.A. Donnan, M.M. Saling, and A.G. Thrift Long-term cognitive transitions, rates of cognitive change, and predictors of incident dementia in a population-based first-ever stroke cohort Stroke 37 2006 2479 2483
70. L. Li, X. Zhang, D. Yang, G. Luo, S. Chen, and W. Le Hypoxia increases Abeta generation by altering beta- and gamma-cleavage of APP Neurobiol Aging 30 2009 1091 1098
71. M.J. Firbank, E.J. Burton, R. Barber, S. Stephens, R.A. Kenny, and C. Ballard Medial temporal atrophy rather than white matter hyperintensities predict cognitive decline in stroke survivors Neurobiol Aging 28 2007 1664 1669
72. C. Cordonnier, H. Henon, P. Derambure, F. Pasquier, and D. Leys Early epileptic seizures after stroke are associated with increased risk of new-onset dementia J Neurol Neurosurg Psychiatry 78 2007 514 516
73. P.S. Sachdev, H. Brodaty, M.J. Valenzuela, L. Lorentz, J.C. Looi, and W. Wen The neuropsychological profile of vascular cognitive impairment in stroke and TIA patients Neurology 62 2004 912 919
74. A. Nordlund, S. Rolstad, O. Klang, K. Lind, S. Hansen, and A. Wallin Cognitive profiles of mild cognitive impairment with and without vascular disease Neuropsychology 21 2007 706 712
75. E.J. Laukka, S. Jones, B.J. Small, L. Fratiglioni, and L. Backman Similar patterns of cognitive deficits in the preclinical phases of vascular dementia and Alzheimer's disease J Int Neuropsychol Soc 10 2004 382 391
76. M.F. Folstein, S.E. Folstein, and P.R. McHugh "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician J Psychiatr Res 12 1975 189 198
77. T. Smith, N. Gildeh, and C. Holmes The Montreal Cognitive Assessment: validity and utility in a memory clinic setting Can J Psychiatry 52 2007 329 332
78. T. Sunderland, J.L. Hill, A.M. Mellow, B.A. Lawlor, J. Gundersheimer, and P.A. Newhouse Clock drawing in Alzheimer's disease. A novel measure of dementia severity J Am Geriatr Soc 37 1989 725 729
79. E.C. Brown, A. Casey, R.I. Fisch, and C. Neuringer Trial making test as a screening device for the detection of brain damage J Consult Psychol 22 1958 469 474
80. S.T. Pendlebury, and P.M. Rothwell Risk of recurrent stroke, other vascular events and dementia after transient ischaemic attack and stroke Cerebrovasc Dis 27 Suppl. 3 2009 1 11
81. T.K. Tatemichi, M. Paik, E. Bagiella, D.W. Desmond, Y. Stern, and M. Sano Risk of dementia after stroke in a hospitalized cohort: results of a longitudinal study Neurology 44 1994 1885 1891
82. R.D. Bell, and B.V. Zlokovic Neurovascular mechanisms and blood-brain barrier disorder in Alzheimer's disease Acta Neuropathol 118 2009 103 113
83. C. Iadecola Cerebrovascular effects of amyloid-beta peptides: mechanisms and implications for Alzheimer's dementia Cell Mol Neurobiol 23 2003 681 689
84. A.D. Korczyn The clinical differential diagnosis of dementia: concept and methodology Psychiatr Clin North Am 14 1991 237 249
85. M.C. Henry-Feugeas MRI of the 'Alzheimer syndrome' J Neuroradiol 34 2007 220 227
86. G.S. Alexopoulos, B.S. Meyers, R.C. Young, S. Campbell, D. Silbersweig, and M. Charlson 'Vascular depression' hypothesis Arch Gen Psychiatry 54 1997 915 922
87. Y. Balash, and A.D. Korczyn Vascular parkinsonism Handb Clin Neurol 84 2007 417 425
88. J.A. Schneider, Z. Arvanitakis, S.E. Leurgans, and D.A. Bennett The neuropathology of probable Alzheimer disease and mild cognitive impairment Ann Neurol 66 2009 200 208
89. L.T. Grinberg, and D.R. Thal Vascular pathology in the aged human brain Acta Neuropathol 119 2010 277 290
90. C.K. Suemoto, R. Nitrini, L.T. Grinberg, R.E. Ferretti, J.M. Farfel, and R.E. Leite Atherosclerosis and dementia: a cross-sectional study with pathological analysis of the carotid arteries Stroke 42 2011 3614 3615
91. L. Pantoni Cerebral small vessel disease: from pathogenesis and clinical characteristics to therapeutic challenges Lancet Neurol 9 2010 689 701
92. K.A. Jellinger The enigma of vascular cognitive disorder and vascular dementia Acta Neuropathol 113 2007 349 388
93. J.E. Simpson, S.B. Wharton, J. Cooper, C. Gelsthorpe, L. Baxter, and G. Forster Alterations of the blood-brain barrier in cerebral white matter lesions in the ageing brain Neurosci Lett 486 2010 246 251
94. M. Takao, A. Koto, N. Tanahashi, Y. Fukuuchi, M. Takagi, and S. Morinaga Pathologic findings of silent, small hyperintense foci in the basal ganglia and thalamus on MRI Neurology 52 1999 666 668
95. F. Fazekas, R. Kleinert, H. Offenbacher, R. Schmidt, G. Kleinert, and F. Payer Pathologic correlates of incidental MRI white matter signal hyperintensities Neurology 43 1993 1683 1689
96. D. Leys, J.P. Pruvo, M. Parent, P. Vermersch, G. Soetaert, and M. Steinling Could Wallerian degeneration contribute to "leuko-araiosis" in subjects free of any vascular disorder? J Neurol Neurosurg Psychiatry 54 1991 46 50
97. P.S. Sachdev, H. Brodaty, M.J. Valenzuela, L.M. Lorentz, and A. Koschera Progression of cognitive impairment in stroke patients Neurology 63 2004 1618 1623
98. T.K. Tatemichi, M. Paik, E. Bagiella, D.W. Desmond, M. Pirro, and L.K. Hanzawa Dementia after stroke is a predictor of long-term survival Stroke 25 1994 1915 1919
99. K.A. Jellinger A critical evaluation of current staging of alpha-synuclein pathology in Lewy body disorders Biochim Biophys Acta 1792 2009 730 740
100. R.N. Kalaria, R.A. Kenny, C.G. Ballard, R. Perry, P. Ince, and T. Polvikoski Towards defining the neuropathological substrates of vascular dementia J Neurol Sci 226 2004 75 80
101. E. Kovari, G. Gold, F.R. Herrmann, A. Canuto, P.R. Hof, and C. Bouras Cortical microinfarcts and demyelination affect cognition in cases at high risk for dementia Neurology 68 2007 927 931
102. K.A. Jellinger Understanding the pathology of vascular cognitive impairment J Neurol Sci 229-230 2005 57 63
103. A. Probst, K.I. Taylor, and M. Tolnay Hippocampal sclerosis dementia: a reappraisal Acta Neuropathol 114 2007 335 345
104. A. Labate, A. Gambardella, U. Aguglia, F. Condino, P. Ventura, and P. Lanza Temporal lobe abnormalities on brain MRI in healthy volunteers: a prospective case-control study Neurology 74 2010 553 557
105. O. Binswanger Die Abgrenzung der allgemeinen progressiven Paralyse Berl Klin Wochenschr. 31 1894 1102 1105
106. W.R. Brown, D.M. Moody, C.R. Thore, J.A. Anstrom, and V.R. Challa Microvascular changes in the white mater in dementia J Neurol Sci 283 2009 28 31
107. Y. Tsushima, J. Aoki, and K. Endo Brain microhemorrhages detected on T2*-weighted gradient-echo MR images Am J Neuroradiol 24 2003 88 96
108. J.T. O'Brien Role of imaging techniques in the diagnosis of dementia Br J Radiol 2007 80 Spec No 2:S71-
109. K. Nagga, C. Radberg, and J. Marcusson CT brain findings in clinical dementia investigation - underestimation of mixed dementia Dement Geriatr Cogn Disord 18 2004 59 66
110. I. Halperin, M. Morelli, A.D. Korczyn, M.B. Youdim, and S.A. Mandel Biomarkers for evaluation of clinical efficacy of multipotential neuroprotective drugs for Alzheimer's and Parkinson's diseases Neurotherapeutics 6 2009 128 140
111. F. Forette, M.L. Seux, J.A. Staessen, L. Thijs, M.R. Babarskiene, and S. Babeanu The prevention of dementia with antihypertensive treatment: new evidence from the Systolic Hypertension in Europe (Syst-Eur) study Arch Intern Med 162 2002 2046 2052
112. K. Shah, S.U. Qureshi, M. Johnson, N. Parikh, P.E. Schulz, and M.E. Kunik Does use of antihypertensive drugs affect the incidence or progression of dementia? A systematic review Am J Geriatr Pharmacother 7 2009 250 261
113. M. Mogi, and M. Horiuchi Effects of angiotensin II receptor blockers on dementia Hypertens Res 32 2009 738 740
114. B. McGuinness, S. Todd, P. Passmore, and R. Bullock Blood pressure lowering in patients without prior cerebrovascular disease for prevention of cognitive impairment and dementia Cochrane Database Syst Rev 2009 CD004034
115. J. Verghese, R.B. Lipton, C.B. Hall, G. Kuslansky, and M.J. Katz Low blood pressure and the risk of dementia in very old individuals Neurology 61 2003 1667 1672
116. J.J. Monsuez, A. Gesquiere-Dando, and S. Rivera Cardiovascular prevention of cognitive decline Cardiol Res Pract. 2011 2011 250970
117. Y. Deschaintre, F. Richard, D. Leys, and F. Pasquier Treatment of vascular risk factors is associated with slower decline in Alzheimer disease Neurology 73 2009 674 680
118. E. Richard, A.A. Gouw, P. Scheltens, and W.A. van Gool Vascular care in patients with Alzheimer disease with cerebrovascular lesions slows progression of white matter lesions on MRI: the evaluation of vascular care in Alzheimer's disease (EVA) study Stroke 41 2010 554 556
119. R. Moretti, P. Torre, R.M. Antonello, and G. Cazzato Rivastigmine in subcortical vascular dementia: a comparison trial on efficacy and tolerability for 12 months follow-up Eur J Neurol 8 2001 361 362
120. M. Dichgans, H.S. Markus, S. Salloway, A. Verkkoniemi, M. Moline, and Q. Wang Donepezil in patients with subcortical vascular cognitive impairment: a randomised double-blind trial in CADASIL Lancet Neurol 7 2008 310 318
121. H. Kavirajan, and L.S. Schneider Efficacy and adverse effects of cholinesterase inhibitors and memantine in vascular dementia: a meta-analysis of randomised controlled trials Lancet Neurol 6 2007 782 792
122. D.F. Muresanu, X.A. Alvarez, H. Moessler, M. Buia, A. Stan, and D. Pintea A pilot study to evaluate the effects of cerebrolysin on cognition and qEEG in vascular dementia: cognitive improvement correlates with qEEG acceleration J Neurol Sci 267 2008 112 119
123. J.J. Secades, and J.L. Lorenzo Citicoline: pharmacological and clinical review, 2006 update Methods Find Exp Clin Pharmacol 28 2006 1 56 Suppl. B
124. O. Napryeyenko, G. Sonnik, and I. Tartakovsky Efficacy and tolerability of Ginkgo biloba extract EGb 761 by type of dementia: analyses of a randomised controlled trial J Neurol Sci 283 2009 224 229
125. W.A. Ray, C.P. Chung, K.T. Murray, K. Hall, and C.M. Stein Atypical antipsychotic drugs and the risk of sudden cardiac death N Engl J Med 360 2009 225 235
126. G. Trifiro, E. Spina, and G. Gambassi Use of antipsychotics in elderly patients with dementia: do atypical and conventional agents have a similar safety profile? Pharmacol Res 59 2009 1 12